ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2023

News provided by

04 May, 2023, 12:08 GMT

GOTHENBURG, Sweden, May 4, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 20%, compared with the previous year.

The revenue in April for Zinzino's sales markets increased by 22% and amounted to SEK 115.9 (95.0) million. Faun Pharma's external sales decreased by 9% and amounted to SEK 5.3 (5.8) million. Overall, the Group increased revenues by 20% to SEK 121.2 (100.8) million compared with the previous year.

Accumulated revenue for January – April 2023 increased by 18% to SEK 514.9 (435.2) million.

Revenues were distributed as follows:

Regions,MSEK	23-Apr	22-Apr	Change	YTD 2023	YTD 2022	Change
The Nordics	21.5	24.5	-12 %	95.0	104.7	-9 %
Central Europe	29.1	19.8	47 %	120.0	78.9	52 %
East Europe	30.5	23.8	28 %	123.1	107.2	15 %
South & West Europe	15.6	11.0	42 %	64.6	49.2	31 %
The Baltics	7.0	5.1	37 %	28.1	23.4	20 %
North America	5.9	4.4	34 %	25.5	18.5	38 %
Asia-Pacific	5.3	5.9	-10 %	20.9	22.3	-6 %
Africa	1.0	0.5	100 %	4.8	1.9	153 %
Zinzino	115.9	95.0	22 %	482.0	406.1	19 %
Faun Pharma	5.3	5.8	-9 %	32.9	29.1	13 %
Zinzino Group	121.2	100.8	20 %	514.9	435.2	18 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa